Who’ll be first? Genomic biomarkers impact on drug discovery and clinical practice

Author： Stallings Sarah C  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.5, Iss.3, 2004-04, pp. : 233-237

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Challenges of biomarkers in drug discovery and development

By Goodsaid Federico  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 6, 2012-06 ,pp. : 457-461

Informa Healthcare

Access to resources Recommend Favorite

Genomic-based biomarkers of drug-induced nephrotoxicity

By Davis John W   Kramer Jeffrey A  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 2, Iss. 1, 2006-02 ,pp. : 95-101

Informa Healthcare

Access to resources Recommend Favorite

Opto-Acoustic Imaging of Drug Discovery Biomarkers

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 11, 2012-09 ,pp. : 2117-2127

Bentham Science Publishers

Access to resources Recommend Favorite

Proteomics: Making Sense of Genomic Information for Drug Discovery

By Whitelegge J.P.  

American Journal of PharmacoGenomics, Vol. 1, Iss. 1, 2001-01 ,pp. : 29-35

Adis International

Access to resources Recommend Favorite

Impact of biomarkers on clinical trial risk

By Reid Geoffrey Gilbert John   Bin Yameen Tarek Abdullah   Parker Jayson Lee  

Pharmacogenomics, Vol. 14, Iss. 13, 2013-10 ,pp. : 1645-1658

Future Medicine

Access to resources Recommend Favorite